Moderna announces Health Canada approves its COVID-19 vaccine
On Sept. 16, 2021, Moderna announced Health Canada had approved the New Drug Submission (NDS-CV) for SPIKEVAX (elasomeran…
-
-
Africa faced 470 million COVID-19 vaccine shortfall in 2021
On Sept. 16, 2021, as the COVAX Facility is forced to slash planned COVID-19 vaccine deliveries to Africa…
-
Biotechnology | Clinical Research | COVID-19 | Infectious Disease | NIH | Non-Profit Research | Therapeutics
NIH builds large nationwide study population of tens of thousands to support research on long-term effects of COVID-19
On Sept. 15, 2021, the National Institutes of Health (NIH) awarded nearly $470 million to build a national…
-
Guinea declared end of Marburg virus disease outbreak
On Sept. 15, 2021, Guinea declared the end of the Marburg virus disease outbreak having recorded no new…
-
Biotechnology | COVID-19 | Diagnostics | FDA
InBios received FDA EUA for COVID-19 IgG antibody rapid test
On Sept. 15, 2021, InBios announced that it had received Emergency Use Authorization from the U.S. Food and…
-
Oragenics initiated COVID-19 challenge study evaluating multiple formulations of its SARS-CoV-2 vaccine candidate
On Sept. 15, 2021, Oragenics announced the initiation of a study to evaluate the immunogenicity and viral load…
-
Emergent BioSolutions announced manufacturing agreement with Providence Therapeutics for mRNA COVID-19 vaccine candidate
On Sept. 14, 2021, Emergent BioSolutions and Providence Therapeutics announced they have entered into a five-year contract development…
-
World global health leaders made urgent call to accelerate vaccination globally
On Sept. 14, 2021, the World Health Organization (WHO) Director General Dr. Tedros Adhanom Ghebreyesus and a group…
-
City of Hope trial was first to test an investigational COVID-19 vaccine in immunocompromised bone marrow transplant
On Sept. 14, 2021, City of Hope announced that it had begun enrolling patients in a Phase 2…
-
Regeneron announced U.S. Government agreement to purchase additional REGEN-COV antibody cocktail
On Sept. 14, 2021, Regeneron announced an agreement with the U.S. Department of Health and Human Services and…
-
Twist Bioscience committed to deliver synthetic RNA controls to fight Delta plus variants of COVID-19
On Sept. 14, 2021, Twist Bioscience announced that it had started shipping its synthetic RNA reference controls for…
-
Misdirected antibodies linked to severe COVID-19
On Sept. 14, 2021, the National Institutes of Health (NIH) announced that an international project called the COVID…
-
US Department of Defense awarded $3.2 billion in contract modifications for monoclonal antibodies
On Sept. 14, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…
-
Twist Bioscience collaborates with Adicet Bio to accelerate discovery of Gamma Delta T cell cancer therapeutics
On Sept. 13, 2021, Twist Bioscience announced and Adicet Bio announced a collaboration to accelerate the discovery of…
-
Atlanta Zoo’s western lowland gorillas tested presumptive positive for COVID-19
On Sept. 10, 2021, Zoo Atlanta reported that it had received presumptive positive test results indicating that members…
-
US Department of Defense awarded $35.8 million contract to Mettler-Toledo Rainin to increase domestic production capacity of pipette tips
On Sept. 10, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…
-
2022 Breakthrough Prize in Life Sciences awarded to Penn Medicine mRNA pioneers Drew Weissman and Katalin Karik
On Sept. 9, 2021, the University of Pennsylvania announced that the Breakthrough Prize in Life Sciences was awarded…
-
Biotechnology | Genomics | NIH | Therapeutics
NIH provided $185 million for research to advance understanding of how human genome functions
On Sept. 9, 2021, the National Institutes of Health (NIH) announced that it was providing approximately $185 million…
-
Novavax initiated phase 1/2 clinical trial of combination vaccine for COVID-19 and seasonal influenza
On Sept. 8, 2021, Novavax announced enrollment of the first participants in a Phase 1/2 study to evaluate…
-
AIM ImmunoTech submitted pre-IND application to FDA for phase 2 clinical study of Ampligen for post-COVID-19 cognitive dysfunction
On Sept. 8, 2021, AIM ImmunoTech announced that is had submitted a Pre-Investigational New Drug application (Pre-IND) to…
-
Resilience to manufacture mRNA for Moderna’s COVID-19 vaccine
On Sept. 8, 2021, National Resilience, a company seeking to build the world’s most advanced biopharmaceutical manufacturing ecosystem,…
-
Bio-Techne and Carterra initiated clinical research collaboration for COVID-19 variant analysis
On Sept. 8, 2021, Bio-Techne and Carterra announced a clinical research collaboration studying COVID-19 variants. To assess immune…
-
Takeda announced manufacture and provision of 150 million doses of Novavax COVID-19 vaccine candidate to the government of Japan
On Sept. 7, 2021, Takeda Pharmaceutical announced the Government of Japan’s Ministry of Health, Labour and Welfare purchase…
-
Biotechnology | COVID-19 | FDA | Pharmaceutical | Therapeutics | Vaccine
Pfizer and BioNTech submitted a variation to EMA with data in support of a booster dose of COMIRNATY
On Sept. 6, 2021, Pfizer and BioNTech announced that they submitted a variation to the European Medicines Agency…
-
Biotechnology | Diagnostics | Disease | Environmental | Genomics | NIH | Oncology
NIH study illuminated origins of lung cancer in never smokers
On Sept. 6, 2021, a genomic analysis of lung cancer in people with no history of smoking has…
-
CDC announced more than $300 million in funding to support community health workers
On Sept. 3, 2021, The Centers for Disease Control and Prevention (CDC) awarded more than $116 million in…
-
Moderna announced submission of data to EMA for its COVID-19 vaccine booster
On Sept. 3, 2021, Moderna announced that it had submitted for a conditional marketing approval (CMA) with the…
-
Coronavirus Epidemics first hit more than 21,000 years ago
On Sept. 2 , 2021, an Oxford University Study showed that the most recent common ancestor of these…
-
Thermo Fisher awarded $192.5 million U.S. government contract to expand domestic pipette tip manufacturing
On Sept. 2, 2021, Thermo Fisher Scientific announced a $192.5 million contract award from the U.S. Department of…
-
COVID-19 | Diagnostics | Infectious Disease | Measles | Plague | Polio | WHO
WHO, Germany opened Hub for Pandemic and Epidemic Intelligence in Berlin
On Sept. 1, 2021, the World Health Organization (WHO) inaugurated the new WHO Hub for Pandemic and Epidemic…
